Amifampridine phosphate

amifampridine phosphate · Catalyst Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Amifampridine phosphate, covering 2018-01-04 to 2024-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis) [Phase 3]

See pricing